CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-27 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +30,000 | 30,000 | ||
| 2022-01-27 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2022-01-27 | Scavilla Daniel T EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2022-01-27 | Demski David M President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +150,000 | 150,000 | ||
| 2022-01-27 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +75,000 | 75,000 | ||
| 2021-09-08 | Davidar David D Director | Gift | −2,000 | 632,775 | ||
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +833 | $49.65 | $41K | 833 |
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −833 | $76.13 | $63K | 0 |
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −833 | 20,000 | ||
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −0 | 24,167 | ||
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +833 | $53.27 | $44K | 833 |
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −833 | $76.13 | $63K | 0 |
| 2021-08-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −833 | 23,334 | ||
| 2021-08-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +833 | $53.27 | $44K | 833 |
| 2021-08-02 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −833 | $83.24 | $69K | 0 |
| 2021-08-02 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −833 | 24,167 | ||
| 2021-07-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +834 | $49.65 | $41K | 834 |
Page 13 of 25 · 498 trades